Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ambu A/S Unsponsored ADR (AMBBY : OTC)

• Company Description    Ambu A/S develops, produces, and sells medical devices to hospitals, clinics and rescue services. It provides anaesthesia, and patient monitoring and diagnostics products. Ambu A/S is based in Ballerup, Denmark. Number of Employees: 5,384

• Price / Volume Information    Yesterday's Closing Price: $10.20 Daily Weekly Monthly 20 Day Moving Average: 243 shares Shares Outstanding: 234.97 (millions) Market Capitalization: $2,396.73 (millions) Beta: 1.06 52 Week High: $16.78 52 Week Low: $9.58 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -4.23% -8.90% 12 Week -18.66% -24.81% Year To Date -22.73% -28.96%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL BALTORPBAKKEN 13 - BALLERUP,G7 DK-2750 DNK ph: 45-7225-2000 fax: - anhj@ambu.com http://www.ambu.com

• General Corporate Information    Officers Britt Meelby Jensen - Chief Executive Officer Jorgen Jensen - Chairman Scott Heinzelman - President Graziela Malucelli - Chief Operations Officer Henrik Skak Bender - Chief Financial Officer Peer Information Ambu A/S Unsponsored ADR (MGLHQ) Ambu A/S Unsponsored ADR (AMBBY) Ambu A/S Unsponsored ADR (HMA.) Ambu A/S Unsponsored ADR (CPMIQ) Ambu A/S Unsponsored ADR (FPAMQ) Ambu A/S Unsponsored ADR (PSYS2) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-HOSPITALS Sector: Medical CUSIP: 02337W109 SIC: 6770 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/28/26 Share - Related Items Shares Outstanding: 234.97 Most Recent Split Date: (:1) Beta: 1.06 Market Capitalization: $2,396.73 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.33% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.03 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.12 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.07 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/28/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 36.43 PEG Ratio: - Price Ratios Price/Book: 2.55 Price/Cash Flow: 16.49 Price / Sales: 2.53 EPS Growth vs. Year Ago Period: -30.00% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 12.44% vs. Previous Quarter: 1.46% ROE 03/31/26 - 8.13 12/31/25 - 9.15 09/30/25 - 10.35 ROA 03/31/26 - 6.45 12/31/25 - 7.27 09/30/25 - 8.20 Current Ratio 03/31/26 - - 12/31/25 - 2.86 09/30/25 - 2.72 Quick Ratio 03/31/26 - - 12/31/25 - 1.67 09/30/25 - 1.63 Operating Margin 03/31/26 - 7.81 12/31/25 - 8.86 09/30/25 - 10.00 Net Margin 03/31/26 - 7.81 12/31/25 - 8.86 09/30/25 - 10.00 Pre-Tax Margin 03/31/26 - - 12/31/25 - 11.06 09/30/25 - 12.51 Book Value 03/31/26 - - 12/31/25 - 4.00 09/30/25 - 3.80 Inventory Turnover 03/31/26 - - 12/31/25 - 1.99 09/30/25 - 1.99 Debt-to-Equity 03/31/26 - - 12/31/25 - 0.08 09/30/25 - 0.08 Debt-to-Capital 03/31/26 - - 12/31/25 - 7.27 09/30/25 - 7.18

Powered by Zacks Investment Research ©